Drug Type Small molecule drug |
Synonyms VU6012962 |
Target |
Action modulators |
Mechanism mGluR7 modulators(Metabotropic glutamate receptor 7 modulators) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
License Organization- |
Drug Highest PhasePendingPreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC21H19F3N4O4 |
InChIKeyIQNLJJLZIVCGFI-UHFFFAOYSA-N |
CAS Registry2313526-86-0 |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Central Nervous System Diseases | Preclinical | United States | 14 Feb 2019 |





